Capecitabine Market Growth and Status Explored in a New Research Report: Fresenius SE & Co. KGaA (Germany), Genentech, Inc. (U.S.), and More…
Capecitabine Market:
Global Capecitabine Market is a chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Cancer is the second leading cause of death worldwide–around 9.6 million deaths every year are caused by cancer, WHO. In addition, more than 70% of deaths occur in low and middle-income countries. Capecitabine has huge potential to meet the increasing need for new agents, which can more aggressively treat breast cancer in the earlier stages. The global capecitabine market accounted for around USD 1,652 million in 2017 and is expected to grow at a healthy CAGR during the forecast period, 2019–2026.
Grab a Free Sample PDF copy of the Capecitabine Market Report 2019 @ https://straitsresearch.com/report/Capecitabine-Market/request-sample
The Major Players Covered in this Report: Fresenius SE & Co. KGaA (Germany), Genentech, Inc. (U.S.), Dr Reddy Laboratories Ltd. (India), Cipla Inc. (India), Accord Healthcare Ltd. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharma B.V., Sandoz Inc. (U.S.), Zentiva N.V. (Netherlands), and Ranbaxy Laboratories Ltd. (India)., & more….
Capecitabine Market Segmentation:
By Application
- Colon Cancer
- Rectal Cancer
- Breast Cancer
- Gastric Cancer
- Others
By Drug Formulation
- Tablets
- Capsules
Intended Audience:
- Capecitabine Manufacturers
- Raw Material Suppliers
- Capecitabine Reselling Companies
- Potential Investors
- Research and Development Institutes
- Traders, Distributors, and Suppliers of Capecitabine
Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/capecitabine-market/global/
Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Capecitabine in the APAC Region:
Asia-Pacific region is anticipated to hold the largest market share in the global Capecitabine market during the forecast period 2017-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Capecitabine and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Capecitabine. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.
Full Report Link @ https://straitsresearch.com/report/Capecitabine-market
TABLES AND FIGURES:
LIST OF TABLES:
TABLE 1 Global Capecitabine Market Share, By Application, 2016 – 2026 ($Million)
TABLE 2 Colon Cancer Capecitabine Market Share, By Region, 2016 – 2026 ($ Million)
TABLE 3 Rectal Cancer Capecitabine Market Share, By Region, 2016 – 2026 ($Million)
TABLE 4 Breast Cancer Capecitabine Market Share, By Region, 2016 – 2026 ($Million)
TABLE 5 Gastric Cancer Capecitabine Market Share, By Region, 2016 – 2026 ($Million)
TABLE 6 Others Capecitabine Market Share, By Region, 2016 – 2026 ($Million)
TABLE 7 Global Capecitabine Market Share, By Drug Formulation, 2016 – 2026 ($Million)
TABLE 8 Global Capecitabine Market Share Value, 2016 – 2026 ($Million)
TABLE 9 America Capecitabine Market Share Value, By Country, 2016 – 2026 ($Million)
TABLE 10 America Capecitabine Market Share value, By Application, 2016-2026 ($Million)
Continue…….
Why Buy This Report?
- Historical inferences, findings & analysis of the market from 2016 to 2018
- Projections and performance forecast analysis for the future from 2019 to 2026
- Production and consumption point of view (POV) analysis
- Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
- Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects
Media Contact
Company Name: Straitsresearch
Contact Person: Veerwati
Email: Send Email
Phone: 6464807505
Address:825 3rd Avenue New York, NY, USA, 10022
City: New York
State: United States
Country: United States
Website: https://straitsresearch.com/
, Genentech, Inc. (U.S.), and More…){kind=link}